Mapk14 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MAPK14 Protein | |
|---|---|
| Protein Name | Mitogen-Activated Protein Kinase 14 |
| Gene | [MAPK14](/genes/mapk14) |
| UniProt ID | [Q16539](https://www.uniprot.org/uniprot/Q16539) |
| Aliases | p38α, RK, CSBP, EXIP |
| Molecular Weight | 41 kDa |
| Protein Kinase Family | MAP kinase (CMGC group) |
| Subcellular Localization | Cytoplasm, Nucleus |
| Expression | Ubiquitous (brain, heart, lung, skeletal muscle) |
MAPK14 (Mitogen-Activated Protein Kinase 14), also known as p38α, is a critical stress-activated protein kinase that plays central roles in cellular responses to inflammation, stress, and injury. As a member of the p38 MAPK family (which includes MAPK11/p38β, MAPK12/p38γ, and MAPK13/p38δ), MAPK14 is activated by cellular stresses including oxidative stress, cytokines, UV radiation, and ischemia. In the nervous system, MAPK14 regulates neuronal survival, neuroinflammation, synaptic plasticity, and responses to neurodegenerative stimuli. MAPK14 has emerged as an important therapeutic target for neurodegenerative diseases due to its dual roles in promoting neuroinflammation and regulating neuronal survival.
MAPK14 is a 360 amino acid serine/threonine protein kinase with a characteristic kinase domain structure:
The protein adopts a typical kinase fold with a two-lobed structure. Activation requires phosphorylation of Thr180 and Tyr182 in the activation loop by upstream MAP kinase kinases (MKK3, MKK4, and MKK6).
MAPK14 participates in numerous normal cellular processes:
Stress Response: MAPK14 is activated by cellular stresses including:
Inflammatory Response: MAPK14 regulates the production of pro-inflammatory mediators:
Cell Cycle and Differentiation: MAPK14 influences cell proliferation, differentiation, and apoptosis in response to environmental signals.
Neuronal Function: In neurons, MAPK14 regulates:
MAPK14 plays complex roles in Alzheimer's disease pathogenesis:
In Parkinson's disease:
In ALS:
In ischemic injury:
MAPK14 is a major drug target for neurodegenerative diseases:
| Drug/Strategy | Mechanism | Development Stage |
|---|---|---|
| SB203580 | ATP-competitive inhibitor | Research tool |
| SB239063 | Selective p38 inhibitor | Preclinical |
| Losmapimod | Brain-penetrant inhibitor | Clinical (stroke, AD) |
| PH-797804 | Selective p38 inhibitor | COPD trials |
| VX-745 | Selective p38α inhibitor | Clinical |
Challenges:
MAPK14 activity can be assessed through:
The study of Mapk14 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.